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ABSTRACT
Individuals with trisomy 21 display complex
phenotypes with differing degrees of severity.
Numerous reliable methods have been established
to diagnose the initial trisomy in these patients, but
the identification and characterization of the genetic
basis of the phenotypic variation in individuals with
trisomy remains challenging. To date, methods that
can accurately determine genotypes in trisomic
DNA samples are expensive, require specialized
equipment and complicated analyses. Here we
report proof-of-concept results for an Invader
assay-based genotyping procedure that can deter-
mine SNP genotypes in trisomic genomic DNA
samples in a simple and cost-effective manner.
The procedure requires only two experimental
steps: a real-time measurement of the fluorescent
Invader signal and analysis with a specifically
designed clustering algorithm. The approach was
tested using genomic DNA samples from 23 individ-
uals with trisomy 21, and results were compared
to genotypes previously determined with pyro-
sequencing. Additional assays for 15 SNPs were
tested in a set of 21 DNA samples to assess assay
performance. Our method successfully identified
the correct SNP genotypes for the trisomic genomic
DNA samples tested, and thus provides an alterna-
tive to determine SNP genotypes in trisomic DNA
samples for subsequent association studies in
patients with Down syndrome and other trisomies.
INTRODUCTION
Down syndrome is the phenotypic manifestation of tris-
omy of chromosome 21 and occurs in one in 800–1000
live births. Current diagnostic methods for detecting
chromosomal abnormalities such as trisomy 21 are well
established clinically. Such methods include karyotyping,
ﬂuorescent in situ hybridization (FISH), quantitative poly-
merase chain reaction (qPCR) (1) and, more recently,
matrix-assisted laser desorption/ionization time-of-ﬂight
(MALDI-TOF) mass spectrometry (2). These techniques
can reliably detect extra chromosome copy numbers, and
thereby help in the clinical diagnosis of trisomies.
However, this diagnosis fails to characterize and explain
the genetic basis for the highly variable clinical presenta-
tion of patients with trisomy 21. It is well known that
certain traits, such as cognitive impairment and dys-
morphic features, occur in all aﬀected individuals to
variable degrees. Most other traits associated with Down
syndrome are seen in only a portion of trisomy 21 individ-
uals and occur with varying degrees of severity.
An extra copy of chromosome 21 should theoretically
result in a 50% increase in gene expression levels for all
genes on that chromosome. However, studies have shown
that there is not always a direct correlation between chro-
mosomal imbalance and gene expression levels (3–5).
Recently, Prandini et al. (6) measured gene expression
levels for 100 and 106 expressed chromosome 21 genes
in lymphocyte and ﬁbroblast cell lines derived from indi-
viduals with trisomy 21, respectively. In their study, they
uncovered considerable gene-expression variation for
many chromosome 21 genes, suggesting that allelic diﬀer-
ences in combination with gene dosage eﬀects are likely
contributing to the phenotypic variability. The ability to
determine if this genotype-speciﬁc eﬀect is contributing
to the resulting variable phenotypes seen in individuals
with trisomy 21, however, requires the ability to quantify
the numbers of each allele present at any variable site on
chromosome 21 in the trisomy samples.
The assessment of allelic diﬀerences in humans is most
often performed using single nucleotide polymorphisms
(SNPs)thatarethemostcommonform ofgeneticvariation
in the human genome. Due to their abundance and their
biallelic nature, SNPs are commonly being used as markers
in human disease studies. Numerous SNP genotyping
methods have been developed that allow the eﬃcient
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DNA samples. In contrast to this well-established geno-
typing methodology for SNPs in chromosomally normal
individuals, genotyping DNA samples from individuals
with trisomy poses a greater challenge since two types of
heterozygotes must be distinguished. The determination
of SNP genotypes in a trisomic population requires
speciﬁc techniques based on allele quantiﬁcation, not just
detection. The most commonly used procedures for deter-
mining SNP genotypes in trisomy include quantitative
ﬂuorescence-PCR (7,8), pyrosequencing (9), restriction
fragment length polymorphism (RFLP) analysis (9,10)
and, more recently, high-density oligonucleotide arrays
(11,12). While accurate, these methods require special
equipment, expensive reagents and complicated analyses,
establishing the need for a new technique that is simple,
eﬃcient and cost-eﬀective, and can be used to interrogate
a small number of speciﬁc SNPs in a study cohort to exam-
ine allelic association with trisomy-related traits.
In 1999, Kwiatkowski et al. (13) developed the Invader
assay for SNP genotyping. This technique uses a
structure-speciﬁc ﬂap endonuclease (FEN) to cleave
a three-dimensional complex formed by hybridization
of allele-speciﬁc overlapping oligonucleotides. When the
oligonucleotide complementary to the SNP allele in
the target molecule anneals, it triggers the cleavage of
the oligonucleotide by a thermostable FEN called clea-
vase. The cleavage product subsequently triggers a second-
ary cleavage reaction on a ﬂuorescence resonance energy
transfer (FRET) probe to generate a ﬂuorescent signal.
This signal ampliﬁcation system can be used to quantify
DNA targets, from both PCR product and genomic
DNA, as well as mRNA targets for gene expression
monitoring (13–18). Genotype data analysis tools have
been developed for the eﬃcient automated computational
assignment of genotype results (18).
In the current study, we demonstrate that a real-time
analysis of the Invader assay and a modiﬁed data analy-
sis clustering algorithm can be used to genotype SNPs
from a trisomic population in a quantitative manner
allowing for allele copy number determination. Further,
we prove the success and accuracy of our technique using
human genomic DNA from individuals with trisomy 21
without prior ampliﬁcation. This novel application of the
Invader assay requires few experimental steps: real-time
measurement of the ﬂuorescent Invader signal followed
by analysis with a clustering algorithm developed in
our laboratory. The speciﬁcity of the Invader assay, the
ability to genotype directly from genomic DNA and the
accurate quantitative determination of allele copy number
all make this approach an appealing alternative for SNP
genotyping in trisomic DNA samples for the analysis of
the genetic basis of trisomy-related phenotypes and their
variability in individuals with Down syndrome.
MATERIALS AND METHODS
DNA
Genomic DNA samples were obtained from peripheral
blood samples collected from 23 individuals with
trisomy 21, as described in Kerstann et al. (9). Addition-
ally, genomic DNA was isolated from 21 commercially
available lymphoblast cell lines derived from individuals
with trisomy 21 (Coriell Cell Repository, Camden, NJ,
USA) and used in the optimization of our protocol. The
study was approved by the Institutional Review Boards of
the Medical College of Wisconsin and Emory University.
Genotyping assays
Invader assays were designed using the InvaderCreator
software (Third Wave Technologies, Madison, Wisconsin,
USA). All assays were designed to be run at the same
incubation temperature (638C). Primary probe oligonu-
cleotides ranged in size from 25 to 30 bases. Prior to use
in the Invader genotyping assay, oligonucleotides were
puriﬁed by HPLC. Each 200mM probe of 100ml were
added to a Falcon 96-well U-bottomed plate (Becton
Dickinson, Franklin Lakes, New Jersey, USA) and
placed in the autosampler of the HPLC system (Hitachi,
Pleasanton, California, USA). The samples were run
through a Tricorn Source 15Q 4.6/100 PE column
(Amersham Biosciences, Pittsburg, Pennsylvania, USA)
with mobile phase buﬀers (pH 7.35) at a ﬂow rate of
1.0ml/min. Fractions of each sample eluting from the
column were collected in 30-s intervals for 1h, while the
absorbance values for each fraction were measured by UV
detector and recorded. Fractions corresponding to the lar-
gest peak on the resulting chromatogram were further
puriﬁed by de-salting using a 10mM sodium phosphate
buﬀer (pH 6.8) and a NAP-10 column (Pharmacia
Biotech, Piscataway, New Jersey, USA), and were eluted
with 1.5ml of milli-Q water.
Genomic DNA samples were diluted to a ﬁnal concen-
tration of 50ng/ml, denatured at 958C for 10min and
placed immediately on ice. Invader reactions were set
up with the following ﬁnal concentrations: 200mMo f
each primary probe, 200mM Invader probe, 10ng/ml
Cleavase XI enzyme, 230mM MgCl2, 2.6M betaine,
1.4mM FRET 1 probe and TE buﬀer (pH 8.0). Invader
assays for each allele of a given SNP were run in separate
plate wells. Plates were run on an ABI 7900 real-time
machine at 958C for 5min followed by incubation at
638C for 7h. During this time readings at 485nm excita-
tion and 530nm emission were recorded for 10s of every
minute for 7h.
Clustering algorithm
The clustering algorithm used in this study represents a
modiﬁed version of the CA clustering algorithm described
previously (18). Raw ﬂuorescence values obtained from
the real-time Invader assay experiments were scaled
to values between 0.05 and 0.95. The CA clustering algo-
rithm was modiﬁed to accommodate a three-allele system
by geometrically separating the cluster space using three
lines instead of two lines to distinguish genotype clusters,
one line to separate the two heterozygous clusters and two
to separate the homozygotes from the heterozygotes.
The lines were created in a manner such that the line
distinguishing the two heterozygous clusters equally
divides an imaginary line that runs from the upper left
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resulting halves were then divided into quarters, with
one-quarter dedicated to the homozygous cluster and
three-quarters to the heterozygous cluster. Data points
were assigned to initial clusters based on the lines created
by ﬁnding the probability ellipses for the points in each
cluster (Figure 1). A probability was calculated for each
point in a cluster using the probability ellipse and the
point was assigned to the cluster where it had the highest
probability.
RESULTS
In this study, we used the Invader assay in combination
with a trisomy-speciﬁc clustering algorithm to accurately
genotype genomic DNA samples with trisomy 21. In this
novel approach, genomic DNA was used directly without
prior ampliﬁcation to interrogate the two alleles of an
SNP separately in a monoplex assay format with the
same ﬂuorescent dye to identify the cleavage products
for each allele. Real-time measurements of the cleavage
products allow for the quantitative determination of
allele copy number, and thus the genotype of the trisomic
DNA. Here, we present data for SNP genotyping of
trisomic DNA, including heterozygous and homozygous
allele combinations, obtained using this new approach for
three representative SNPs on chromosome 21. Results
from these Invader assays were compared with results
obtained previously by pyrosequencing using the same
genomic DNA samples and SNP assays.
Real-time analysis
In order to alleviate any potential bias in allele ampliﬁca-
tion during PCR, we conducted our genotyping of trisomy
21 DNA experiments using genomic DNA. All genomic
DNA samples were manually loaded in triplicate into
a 384-well plate, denatured on a GeneAmp 9700 thermo-
cycler (Applied Biosystems) for 10min at 958C and imme-
diately placed on ice to stop the denaturation process.
Invader assay reagents for three SNPs (Table 1) were
added to the denatured DNA samples in a monoplex
assay format and incubated in an ABI 7900. For each
genomic DNA sample and SNP Invader assay reaction
ﬂuorescence data were averaged and recorded across 10s
of every minute for 7h. These data were then averaged
across replicates and plotted against time in minutes, with
the resulting curves representing the quantity of each SNP
allele detected over time. Figure 2 illustrates the ﬂuores-
cence measures for allele ‘A’ of SNP rs874221 in six dif-
ferent trisomic DNA samples as ﬂuorescence of FAM
Table 1. Assay Primer and Probe Sequences
dbSNP PCR primers Sequence primer
SNPs genotyped by Pyrosequencing
rs2837043 50-
 GTAGGGAAGGGAATGGAGGGTCT-30 50-GGCATGAGGCCAG-30
50-CCTGGACGGCAAGTGACTGT-30
rs2837042 50-CATAATGATATATACCCTTACA-30 50-AGGTAAGATCTCGATTCAA-30
50-
 AAATCTGATAAAACCTACCT-30
rs874221 50-
 TGATAAAGCAAACTGGGATGAC-30 50-TGCACACTTGTGAGCC-30
50-CCAAACAAGGAAGGAATAAA-30
dbSNP Primary probes Invader probe
SNPs genotyped by Invader assays
rs2837043 50-CGCGCCGAGGTTCAGCTGGCCTCAT-30
50-CGCGCCGAGGGTCAGCTGGCCTCA-30
50-GAATGTGAACTTCTTATATAGACCCCTTGTTTTC
AGTATGGTTGCCTACC-30
rs2837042 50-CGCGCCGAGGATTGAATCGAGATCTTACCTG-30
50-CGCGCCGAGGGTTGAATCGAGATCTTACCT-30
50-AGATGAGACGTCACTGGAAGAAAAAAATCTGATA
AAACCTACCTTGTCT-30
rs874221 50-CGCGCCGAGGTGGCTCACAAGTGTG-30
50-CGCGCCGAGGCGGCTCACAAGTGTG-30
50-TGTGAGCTCCTAACTTAAGGACTAAGAAATACAAA
AGATCAGTTTCCGTAAATAAACA-30
PCR primers and sequence primers for three SNPs genotyped with pryrosequencing (top) and probe sequences for the same three SNPs genotyped
with Invader assays.
Figure 1. Sector deﬁnition for trisomy CA clustering algorithm (with
idealized data). The initial ﬁve cluster areas deﬁned by the heuristic part
of the clustering algorithm. The circles denote the centers of gravity of
the homozygote clusters. The line connecting the centers is the basis for
dividing the initial sectors. The line is bisected and the resulting halves
are divided again, with one-quarter devoted to the homozygote cluster
and three-quarters to the heterozygote cluster. This ratio is empirically
derived from test data sets. These points along the line connect to the
center of the negative control cluster to deﬁne the four initial sectors.
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In the ﬁgure, the relative ﬂuorescence signal obtained
from the Invader cleavage reaction was plotted along
the y-axis, while time was plotted along the x-axis. The
ﬂuorescence values as measured at 485nm excitation and
530nm emission represent a quantitative measure of SNP
rs874221 allele ‘A’ in each of the trisomic DNA samples.
End-point determination and optimization
To determine the time point that most clearly distin-
guished between ﬂuorescence curves, and therefore allele
quantity, we created scatter plots of ﬂuorescence values
taken every 30min across the 7-h recording period for
the three SNPs of interest in this study. In these plots,
the ﬂuorescence of allele ‘A’ for a given SNP was plotted
against the ﬂuorescence of allele ‘B’ for the same SNP at
a given time point for 10 trisomic DNA samples run in
duplicate. This was completed for all three SNPs of inter-
est. For each of the SNPs, all time points from 210 to
300min could accurately be used to create scatter plots
that showed clear separation of clusters and allowed
for genotype determination of DNA samples (Figure 3),
whereas earlier time points could not clearly distinguish
clusters. Any of these time points could then be used as
end-point measurements for future genotyping studies
using this SNP assay, thereby eliminating the need to
run additional real-time studies and allowing the use of
only a thermocycler and ﬂuorescence plate reader for
trisomic DNA genotyping.
Clustering
We conﬁrmed our genotype determinations in these triso-
mic DNA samples by applying a clustering algorithm
to the data from an end-point time identiﬁed previously
(any time point between 210 and 300min). The clustering
algorithm used was a modiﬁed version of the CA cluster-
ing algorithm, which assigns individual data points to a
predetermined number of clusters based on standard
Figure 3. Multiple time point scatterplots for rs874221. End-point genotype determinations for 60 and 270min with trisomy 21 DNA cell lines are
shown. Early time points cannot accurately identify genotypes. However, time points from 210 to 300min can be reliably used to determine
genotypes for this SNP using the modiﬁed clustering algorithm. Shown are genotype clusters with points in blue representing samples with the
GGG genotype, green representing GGA samples, teal representing AAG and purple representing samples with the AAA genotype.
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Figure 2. Trisomic genomic DNA genotyping using real-time Invader
assay. Real-time ﬂuorescence curves for six diﬀerent trisomy 21 geno-
mic DNA samples generated during real-time Invader cleavage
reaction. Only the ﬂuorescence from one FAM probe (FAM probe 2,
speciﬁc for allele ‘A’) is shown. The amount of allele-speciﬁc ﬂuores-
cence corresponds to the copy number of that allele in each DNA
sample.
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centroid of each cluster. To account for the extra genotype
cluster of trisomy samples, the original algorithm was
modiﬁed by adding an extra line to distinguish the two
heterozygote clusters in addition to the two previously
existing lines that separate the heterozygotes from the
homozygote clusters.
This algorithm was used to verify the genotype determi-
nations of DNA samples from all 23 individuals with
trisomy 21 and Invader assays for three SNPs on chro-
mosome 21 to determine genotype calls, using 90%
probability as our cutoﬀ. Because of these stringent
speciﬁcations, any data point with <90% probability of
residing within a given cluster would be considered a
‘no call’ by the algorithm. This assures accuracy in our
genotype calls and increases the likelihood of distinguish-
ing between the two heterozygous clusters.
Comparison to pyrosequencing genotype calls
Only those genotype results that were conﬁdently called by
the clustering algorithm (cluster probability of >90%)
were compared with the genotypes determined by pyrose-
quencing. For SNPs rs2837043 and rs874221, the geno-
type calls determined by real-time Invader for all
samples tested correctly matched the genotype determina-
tion by pyrosequencing demonstrating 100% concor-
dance. For SNP rs2837042, one discrepant call was
obtained when calls from Invader genotyping were com-
pared to pyrosequencing. While only one sample yielded a
discrepant call, 17% of genotyping calls failed altogether,
i.e. no genotype could be assigned due to low levels of
detected ﬂuorescence. The relatively high failure rate can
be attributed to the DNA quality used for these experi-
ments In fact, an additional ﬁve DNA samples tested were
excluded from the data analysis since none of the SNPs
yielded any successful genotype calls.
Analysis ofinvader assayperformance
In order to better assess the genotype call rate using this
Invader assay approach, we genotyped 21 additional tris-
omy 21 DNA samples for 15 additional chromosome 21
SNPs. All SNPs were genotyped successfully, and ana-
lyzed as described above; however, we did not have inde-
pendent veriﬁcation of our genotype calls for these
samples. Across all 15 SNPs, we observed a genotype
call failure rate of 15.2% (0–80%) for the DNA samples
used. Seven DNA samples had failure rates of >15%
across the 15 SNPs. When these DNA samples are not
included in the analysis, the average failure rate across
the remaining 14 DNA samples for all 15 SNPs is 7.5%,
a failure rate comparable to other genotyping platforms,
such as Invader assay in chromosomally normal samples
[2.3–3.2%, (19,20)], MassArray [6.4%, (21)] or FP-TDI
[32.3%, (21)]. This observation suggests that a signiﬁcant
portion of the high failure rate observed in our genotyping
can be attributed to speciﬁc DNA samples, such as DNA
purity, concentration or fragmentation.
DISCUSSION
We have developed a novel genotyping procedure that
allows accurate trisomy genotype calls to be determined
from real-time Invader assay ﬂuorescence data in combi-
nation with a trisomy-speciﬁc clustering algorithm,
modiﬁed from the CA clustering algorithm described by
Olivier et al. (18). The new method has been developed
to eliminate the need for ampliﬁcation of DNA prior to
genotyping with the Invader assay, as has been shown in
several other studies (15,17,22,23). Eliminating the PCR
step alleviates any potential allele-speciﬁc ampliﬁcation
that may signiﬁcantly impact the genotyping results,
which are based on allele quantiﬁcation. Thus, it decreases
the number of false genotype calls that could result
from PCR.
Our technique is signiﬁcantly diﬀerent from the other
available options for trisomy genotyping in several addi-
tional respects: (i) it requires only a thermocycler or real-
time quantitative PCR machine with no need for other
more advanced specialized equipments; (ii) the analysis
of results is simple, straightforward and can be performed
using Microsoft Excel; and the trisomy-speciﬁc clustering
algorithm that uses probability functions to assign data
points to four separate genotype clusters; (iii) most impor-
tantly, the real-time Invader reactions need only be run
once for each SNP assay to determine the time points that
are optimal for cluster diﬀerentiation. After the ideal time
points have been determined for a given SNP they can be
used as end-point measurements for any future genotyp-
ing of that SNP on any sample. Subsequent genotyping
requires only a thermocycler to run the Invader reaction
and a ﬂuorometer to measure the end-point ﬂuorescence
values that can be used for the clustering algorithm.
To assess the accuracy of our genotyping method,
we used pyrosequencing results that had previously been
determined and published (9) for these DNA samples and
SNPs as an independent veriﬁcation of our results. When
we compared the genotype calls from both methods,
we observed a 100% concordance with pyrosequencing
calls for SNPs rs2837043 and rs874221. The third SNP
we investigated, rs2837042, was a predominantly homozy-
gous SNP. As a consequence, the samples we genotyped
only represented two genotype clusters, one homozygous
and one heterozygous cluster. This signiﬁcantly reduces
the accuracy and the conﬁdence of genotyping assign-
ments based on geometric clustering. Despite this limita-
tion, when the data was analyzed by the clustering
algorithm, 88% of the genotype calls still matched those
of pyrosequencing. The average concordance of our geno-
typing method with pyrosequencing was  96%. While
this degree of agreement is encouraging, the overall failure
rate of genotype calls is a concern. The reasons for this are
unclear but could potentially be DNA sample related.
Alternatively, assay probes may not have been puriﬁed
suﬃciently, resulting in background ﬂuorescence in the
assay. This SNP also showed one discordant call, suggest-
ing that the assay conditions or data analysis needs to be
optimized. However, it is important to note that this dis-
cordant call could also be the result of a miscall by the
pyrosequencing method. Although pyrosequencing is a
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error that exist with this technology. Previous studies by
our group comparing Taqman genotyping and Invader
assay genotyping demonstrated that discordant genotyp-
ing calls are equally likely in both methods (18). Based on
these results, it is conceivable that the same error rates
extend to pyrosequencing.
Our detailed analysis of the performance of 15 addi-
tional SNP assays using 21 DNA samples isolated from
commercially available trisomy 21 cell lines suggests that
the overall failure rate for genotyping of trisomic samples
is as low as 7.5%. In fact, four of these SNPs were success-
fully genotyped for all DNA samples, indicating that the
method may be susceptible to SNP-speciﬁc complications
and DNA quality that could be overcome with additional
assay optimization.
The development of SNP genotyping methods for triso-
mic populations is an important step in our eﬀort to better
understand the role that SNPs play in determining the
many phenotypes exhibited by individuals with chromo-
somal duplications. The application of the Invader assay
to trisomic DNA samples combined with the use of geno-
mic DNA and a trisomy-speciﬁc clustering algorithm
represents a novel procedure for determining SNP geno-
types in a trisomic population. While the work presented
here demonstrates proof-of-concept, improvements in the
sensitivity and assay accuracy are necessary. However,
this new method does present a simple and inexpensive
alternative to current trisomy genotyping techniques and
because it does not require specialized equipment it can be
performed in almost any genetics laboratory. Data pre-
sented here on a total set of 18 SNPs suggest that assays
can be designed successfully to any SNP, and only minor
optimization is required to improve assay call rates and
performance for application of the methodology to asso-
ciation analyses trying to uncover the genetic basis of
phenotypic variation in individuals with Down syndrome
and other trisomies.
In addition to the described application to SNP geno-
typing, the technology is also potentially adaptable
and suitable for other clinically relevant applications.
Optimized assays with improved accuracy and reduced
failure rate could potentially be cost-eﬃcient alternatives
for clinical genotyping and trisomy detection. In addition,
the ability of the assay to quantitatively measure allele
copy numbers could be exploited to develop alternative
approaches to detect copy number variants in human
DNA samples. However, further testing and optimization
of individual assays will be required to validate the tech-
nology for these additional applications, and it remains to
be seen whether Invader technology would be superior
to other already existing platforms for these applications.
The CA tool is available from the corresponding author
upon request.
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